IN2014MN02275A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN02275A IN2014MN02275A IN2275MUN2014A IN2014MN02275A IN 2014MN02275 A IN2014MN02275 A IN 2014MN02275A IN 2275MUN2014 A IN2275MUN2014 A IN 2275MUN2014A IN 2014MN02275 A IN2014MN02275 A IN 2014MN02275A
- Authority
- IN
- India
- Prior art keywords
- plasmodium
- against malaria
- host
- vertebrate
- rodent plasmodium
- Prior art date
Links
- 241000224016 Plasmodium Species 0.000 abstract 4
- 241000283984 Rodentia Species 0.000 abstract 3
- -1 ganism Species 0.000 abstract 3
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 2
- 201000004792 malaria Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000001524 infective effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT10626212 | 2012-04-17 | ||
| PCT/IB2013/053050 WO2013156949A1 (en) | 2012-04-17 | 2013-04-17 | Rodent plasmodium parasites as platforms for a whole-organism malaria vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02275A true IN2014MN02275A (enExample) | 2015-08-07 |
Family
ID=48539330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2275MUN2014 IN2014MN02275A (enExample) | 2012-04-17 | 2013-04-17 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9655957B2 (enExample) |
| EP (1) | EP2838554B1 (enExample) |
| JP (1) | JP6096884B2 (enExample) |
| CN (1) | CN104302313B (enExample) |
| AU (1) | AU2013250814B2 (enExample) |
| BR (1) | BR112014025823A8 (enExample) |
| IN (1) | IN2014MN02275A (enExample) |
| PT (1) | PT2838554T (enExample) |
| WO (1) | WO2013156949A1 (enExample) |
| ZA (1) | ZA201408440B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104771752B (zh) * | 2015-04-21 | 2018-01-05 | 中国人民解放军第三军医大学 | 疟疾红内期灭活全虫疫苗的新用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0417762A8 (pt) * | 2003-12-19 | 2015-12-22 | Seattle Biomedical Res Institute | Organismo vivo, um plasmodium, método para inocular um hospedeiro vertebrado contra malária, composição de vacina, uso de um organismo vivo, um plasmodium, e, método de produção de uma composição de vacina |
| US7722860B2 (en) * | 2004-12-03 | 2010-05-25 | Seattle Biomedical Research Institute | Live genetically engineered protozoan vaccine |
| FR2978048B1 (fr) * | 2011-07-20 | 2014-10-10 | Univ Paris Curie | Composition vaccinale contre le paludisme |
-
2013
- 2013-04-17 IN IN2275MUN2014 patent/IN2014MN02275A/en unknown
- 2013-04-17 US US14/394,964 patent/US9655957B2/en active Active
- 2013-04-17 CN CN201380020546.7A patent/CN104302313B/zh not_active Expired - Fee Related
- 2013-04-17 PT PT13726295T patent/PT2838554T/pt unknown
- 2013-04-17 EP EP13726295.2A patent/EP2838554B1/en not_active Not-in-force
- 2013-04-17 WO PCT/IB2013/053050 patent/WO2013156949A1/en not_active Ceased
- 2013-04-17 JP JP2015506341A patent/JP6096884B2/ja not_active Expired - Fee Related
- 2013-04-17 AU AU2013250814A patent/AU2013250814B2/en not_active Expired - Fee Related
- 2013-04-17 BR BR112014025823A patent/BR112014025823A8/pt not_active IP Right Cessation
-
2014
- 2014-11-17 ZA ZA2014/08440A patent/ZA201408440B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6096884B2 (ja) | 2017-03-15 |
| WO2013156949A1 (en) | 2013-10-24 |
| AU2013250814A1 (en) | 2014-12-04 |
| HK1206243A1 (en) | 2016-01-08 |
| BR112014025823A2 (enExample) | 2017-06-20 |
| CN104302313B (zh) | 2018-01-26 |
| US20150071966A1 (en) | 2015-03-12 |
| PT2838554T (pt) | 2018-11-23 |
| JP2015514745A (ja) | 2015-05-21 |
| EP2838554B1 (en) | 2018-08-22 |
| CN104302313A (zh) | 2015-01-21 |
| BR112014025823A8 (pt) | 2017-07-25 |
| AU2013250814B2 (en) | 2017-03-02 |
| US9655957B2 (en) | 2017-05-23 |
| EP2838554A1 (en) | 2015-02-25 |
| ZA201408440B (en) | 2015-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018501515B1 (en) | Parenteral novovirus vaccine formulations | |
| PH12017500727A1 (en) | Modified virus-like particles of cmv | |
| MX2018013668A (es) | Inhibidores de virus de hapatitis c. | |
| MX342716B (es) | Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza. | |
| SG10201903349YA (en) | Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy | |
| EA201890942A1 (ru) | Мультивалентные вакцины с синтетическими наноносителями | |
| EA201290876A1 (ru) | Композиции индуцированных дендритных клеток и их использование | |
| EA201391515A1 (ru) | Инактивированная вакцина вируса денге | |
| MY168959A (en) | Vaccine compositions for the prevention of dengue virus infection | |
| PH12014502875A1 (en) | Vaccine compositions for prevention against dengue virus infection | |
| MX2013013801A (es) | Oligodesoxinucleotidos inmunoestimuladores. | |
| EP2679683A4 (en) | NEW VARICELLA ZOSTER VIRUSES AND WINDPOCK AND HERPES ZOSTER VIRUS VACCINE THEREOF | |
| MX2013003470A (es) | Estructuras de consenso de antigenos y vacunas elaboradas a partir de estas y metodos para utilizarlas en el tratamiento de la malaria. | |
| NZ715459A (en) | A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same | |
| PH12014501388A1 (en) | A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv | |
| NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
| IN2015KN00516A (enExample) | ||
| MA37749A1 (fr) | Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine | |
| MX344544B (es) | Vacuna para paludismo en etapa sanguinea. | |
| EP3908315A4 (en) | COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSE TO VACCINATION AND ENHANCING VACCINE PRODUCTION | |
| GB201112587D0 (en) | Vaccine | |
| BR112014025823A8 (pt) | Parasitas plasmodium de roedores utilizados como plataformas para uma vacina contra a malária á base de organismos inteiros | |
| PL406631A1 (pl) | Antygen, szczepionka przeciwko grypie, układ do wytwarzania szczepionki, sposób wytwarzania antygenu oraz zastosowanie antygenu określonego powyżej do wytwarzania szczepionki przeciwko grypie | |
| WO2012134591A3 (en) | Plasmodium falciparum antigens | |
| Lee et al. | Development of a Traveler’s Vaccine against Dengue Infection |